Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
PDB: 19 件

3IP2
DownloadVisualize
BU of 3ip2 by Molmil
Crystal structure of red fluorescent protein Neptune at pH 7.0
分子名称: Neptune red fluorescent protein
著者Lin, M.Z, McKeown, M.R, Ng, H.L, Aguilera, T.A, Shaner, N.C, Ma, W, Adams, S.R, Campbell, R.E, Alber, T, Tsien, R.Y.
登録日2009-08-15
公開日2009-12-15
最終更新日2023-11-22
実験手法X-RAY DIFFRACTION (1.6 Å)
主引用文献Autofluorescent proteins with excitation in the optical window for intravital imaging in mammals.
Chem.Biol., 16, 2009
5BQL
DownloadVisualize
BU of 5bql by Molmil
Fluorescent protein cyOFP
分子名称: Fluorescent protein cyOFP
著者Sens, A, Ataie, N, Ng, H.L, Lin, M.Z, Chu, J.
登録日2015-05-29
公開日2016-06-01
最終更新日2019-12-18
実験手法X-RAY DIFFRACTION (2.39 Å)
主引用文献A Guide to Fluorescent Protein FRET Pairs.
Sensors Basel Sensors, 16, 2016
6WEM
DownloadVisualize
BU of 6wem by Molmil
Crimson 0.9
分子名称: mCrimson 0.9
著者Ataie, N, Tran Tang, C, Sens, A, Lin, M.Z, Chu, J, Ng, H.L.
登録日2020-04-02
公開日2021-04-07
最終更新日2023-11-15
実験手法X-RAY DIFFRACTION (2.04 Å)
主引用文献Crimson 0.9
To Be Published
8EZV
DownloadVisualize
BU of 8ezv by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML2006a
分子名称: (1R,2S,5S)-N-{(2S,3R)-4-(azetidin-1-yl)-3-hydroxy-4-oxo-1-[(3S)-2-oxopiperidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase nsp5
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2022-11-01
公開日2023-10-11
最終更新日2024-03-20
実験手法X-RAY DIFFRACTION (1.8 Å)
主引用文献An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
Sci Transl Med, 16, 2024
8EZZ
DownloadVisualize
BU of 8ezz by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML2006a2
分子名称: (1R,2S,5S)-N-{(2S,3R)-4-(3,3-difluoroazetidin-1-yl)-3-hydroxy-4-oxo-1-[(3S)-2-oxopiperidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase nsp5, CHLORIDE ION
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2022-11-01
公開日2023-10-11
最終更新日2024-03-20
実験手法X-RAY DIFFRACTION (1.85 Å)
主引用文献An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
Sci Transl Med, 16, 2024
8F2D
DownloadVisualize
BU of 8f2d by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML4006a
分子名称: (1R,2S,5S)-N-[(2S,3R)-4-(azetidin-1-yl)-3-hydroxy-4-oxo-1-(2-oxopiperidin-1-yl)butan-2-yl]-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase nsp5, CHLORIDE ION
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2022-11-07
公開日2023-10-11
最終更新日2024-03-20
実験手法X-RAY DIFFRACTION (1.95 Å)
主引用文献An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
Sci Transl Med, 16, 2024
8F02
DownloadVisualize
BU of 8f02 by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML2006a4
分子名称: (1R,2S,5S)-N-{(2S,3R)-4-(3,3-dimethylazetidin-1-yl)-3-hydroxy-4-oxo-1-[(3S)-2-oxopiperidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase nsp5
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2022-11-01
公開日2023-10-11
最終更新日2024-03-20
実験手法X-RAY DIFFRACTION (2 Å)
主引用文献An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
Sci Transl Med, 16, 2024
8F2C
DownloadVisualize
BU of 8f2c by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML3006a
分子名称: (1R,2S,5S)-N-[(2S,3R)-4-(azetidin-1-yl)-3-hydroxy-4-oxo-1-(2-oxopyrrolidin-1-yl)butan-2-yl]-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase nsp5, CHLORIDE ION
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2022-11-07
公開日2023-10-11
最終更新日2024-03-20
実験手法X-RAY DIFFRACTION (1.95 Å)
主引用文献An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
Sci Transl Med, 16, 2024
7SF3
DownloadVisualize
BU of 7sf3 by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML1006m
分子名称: (1R,2S,5S)-N-{(2S,3R)-3-hydroxy-4-(methylamino)-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase, CHLORIDE ION
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2021-10-02
公開日2022-10-05
最終更新日2024-04-17
実験手法X-RAY DIFFRACTION (1.75 Å)
主引用文献An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
Sci Transl Med, 16, 2024
7SFH
DownloadVisualize
BU of 7sfh by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML102
分子名称: (1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-(3-phenylpropanoyl)-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase, CALCIUM ION
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2021-10-03
公開日2022-10-05
最終更新日2023-10-18
実験手法X-RAY DIFFRACTION (1.4 Å)
主引用文献Rational design of a new class of protease inhibitors for the potential treatment of coronavirus diseases
To Be Published
7SGH
DownloadVisualize
BU of 7sgh by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML124N
分子名称: (S)-N-((S)-1-imino-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-4-methyl-2-(2-((2,4,6-trifluorophenyl)amino)acetamido)pentanamide, 3C-like proteinase
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2021-10-05
公開日2022-10-05
最終更新日2023-10-18
実験手法X-RAY DIFFRACTION (1.85 Å)
主引用文献Rational design of a new class of protease inhibitors for the potential treatment of coronavirus diseases
To Be Published
7SFB
DownloadVisualize
BU of 7sfb by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML101
分子名称: 3C-like proteinase, DI(HYDROXYETHYL)ETHER, TRIETHYLENE GLYCOL, ...
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2021-10-03
公開日2022-10-05
最終更新日2023-10-18
実験手法X-RAY DIFFRACTION (1.9 Å)
主引用文献Rational design of a new class of protease inhibitors for the potential treatment of coronavirus diseases
To Be Published
7SFI
DownloadVisualize
BU of 7sfi by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML104
分子名称: (1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[N-(2,4,6-trifluorophenyl)glycyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase, CALCIUM ION, ...
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2021-10-03
公開日2022-10-05
最終更新日2023-10-18
実験手法X-RAY DIFFRACTION (1.95 Å)
主引用文献Rational design of a new class of protease inhibitors for the potential treatment of coronavirus diseases
To Be Published
7SET
DownloadVisualize
BU of 7set by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML1000
分子名称: (1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase, CHLORIDE ION
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2021-10-01
公開日2022-10-05
最終更新日2024-04-17
実験手法X-RAY DIFFRACTION (1.7 Å)
主引用文献An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
Sci Transl Med, 16, 2024
7SF1
DownloadVisualize
BU of 7sf1 by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML1001
分子名称: (1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(3,3-dimethylbutanoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2021-10-02
公開日2022-10-05
最終更新日2024-04-17
実験手法X-RAY DIFFRACTION (1.85 Å)
主引用文献An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
Sci Transl Med, 16, 2024
4OQW
DownloadVisualize
BU of 4oqw by Molmil
Crystal structure of mCardinal far-red fluorescent protein
分子名称: Fluorescent protein FP480
著者Burg, J.S, Chu, J, Lam, A.J, Lin, M.Z, Garcia, K.C.
登録日2014-02-10
公開日2014-03-12
最終更新日2014-05-14
実験手法X-RAY DIFFRACTION (2.21 Å)
主引用文献Non-invasive intravital imaging of cellular differentiation with a bright red-excitable fluorescent protein.
Nat.Methods, 11, 2014
7UUG
DownloadVisualize
BU of 7uug by Molmil
SARS-CoV-2 Main Protease S144A (Mpro S144A) in Complex with ML1006a
分子名称: (1R,2S,5S)-N-{(2S,3R)-4-(azetidin-1-yl)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase nsp5, CHLORIDE ION
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2022-04-28
公開日2023-10-11
最終更新日2024-03-20
実験手法X-RAY DIFFRACTION (2 Å)
主引用文献An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
Sci Transl Med, 16, 2024
7UUP
DownloadVisualize
BU of 7uup by Molmil
SARS-CoV-2 Main Protease S144A (Mpro S144A) in Complex with Nirmatrelvir (PF-07321332)
分子名称: (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase nsp5, CHLORIDE ION
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2022-04-28
公開日2023-10-11
最終更新日2024-03-20
実験手法X-RAY DIFFRACTION (2 Å)
主引用文献An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
Sci Transl Med, 16, 2024
7U92
DownloadVisualize
BU of 7u92 by Molmil
SARS-CoV-2 Main Protease (Mpro) in Complex with ML1006a
分子名称: (1R,2S,5S)-N-{(2S,3R)-4-(azetidin-1-yl)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase, CHLORIDE ION
著者Westberg, M, Fernandez, D, Lin, M.Z.
登録日2022-03-09
公開日2023-09-06
最終更新日2024-03-20
実験手法X-RAY DIFFRACTION (1.8 Å)
主引用文献An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
Sci Transl Med, 16, 2024

222036

件を2024-07-03に公開中

PDB statisticsPDBj update infoContact PDBjnumon